Consumer Spending is Expected to Cool in Russia’s Pharmaceuticals & Healthcare Sector
14 October 2013
Business Monitor examines key issues affecting the Pharmaceuticals and healthcare industry in Russia and provides short- and long-term forecasts for the sector.
Elsevier Contributes Scopus Data to Development of Russian Map of Science
14 October 2013
Russian Ministry of Education has signed an agreement to include Scopus Custom Data in the development of a national research assessment tool Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the Russian Ministry of Education and Science has signed an agreement to include Scopus Custom Data in a nation-wide research assessment tool: Russia's Map of Science.
Siberian scientists develop nanodrugs to fight cancer; regulators give green light
11 October 2013
Siberian researchers at Tomsk Polytechnic University’ Institute of High Technology Physics have developed what they call “nanodrugs” based on organic synthesis to fight various cancers, E-News reported .
Ophthalmologists urged Russians to check sight by means of the Internet
11 October 2013
In the World Day of sight which is celebrated on October 10, ophthalmologists urged people not to forget about importance of prevention of a disease of eyes. As it is noted in the press release which has arrived in edition KM.RU, not all needing correction of sight address to experts. Data of the conducted researches showed that only 10 percent of Russians annually visit the ophthalmologist for survey. Now will be able to prove gravity of the intentions now to any Internet polzoval.
Indian companies leave footprints on Russian generic drug market
07 October 2013
Ranbaxy, India’s largest generic drug manufacturer announced the completion of 20 years in Russia. It is among many Indian players struggling against tough competition from European and domestic drug manufacturers in Russian emerging generic drugs market.
ROSNANO will allocate additional financing to “Russian Membranes”
04 October 2013
The board of directors at the meeting in absentia has taken decision about changing the main parameters of ROSNANO participation in the investment project “Russian Membranes: modern production establishment of nano-structural membranes and separation modules on its basis”.
Dmitry Medvedev: Development of “Skolkovo” will be continued
04 October 2013
In the article, named as “Time of simple solutions has gove”, the Head of Government says about reset of import taxes for scientific equipment and materials, and calls large Russian companies to invest money in science more actively, and Government – find opportunities to stimulate such investments.
The portfolio Company of ROSNANO “BIND Therapeutics” has conducted IPO at NAS
01 October 2013
BIND Therapeutics, Inc., the portfolio company of ROSNANO, has finished the IPO of 4.700.000 common shares. Cost of IPO comprised $15.00 per one share. In the result of BIND Therapeutics’s IPO, there has been attracted $70.5M (before the discount and underwriters’ commission deduction).
26 September 2013
With Russia pegged as one of the world's fastest-growing markets, drug makers have been angling to build up their businesses here. For free access to the market, the Russian government now requires foreign companies to team up with local players – and to share technology with them.
Pharma packaging growing market with openings for good ideas
26 September 2013
Market expected to grow at 5.6% annually through 2018.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Russian government will support the development and production of modern drugs
16 September 2024
Russia’s Long-Lasting Flu Vaccine Undergoes Trials
16 September 2024
Moscow to Launch Digitalization Course for Students
12 September 2024
Russia has created an oral drug aimed at treating obesity and diabetes
12 September 2024